Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs Hers

Found
Site position #8

Higher grade

Hers
Site position #359

Lower grade

The verdict

Found takes it — 83.5/100 to 60.7/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFound +24
78
54
Dose & formulationFound +17
94
77
Clinical oversightFound +31
86
55
Labs & monitoringFound +30
82
52
FulfillmentFound +3
84
81
Contract termsFound +29
70
41
Found · top barHers · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFoundHers
WeighScore83.5/10060.7/100
GradeBC
Site position#8#359
Semaglutide$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copayFrom $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo)
Tirzepatide$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both moleculesFrom $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo)
CoverageAll 50 statesNot available in every state; confirm eligibility
Brand-name accessYesYes
Oral / sublingualYesYes
Found

Site position #8 · B

Strengths

  • Widest medication list in this ranking — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
  • Flat pricing as the dose increases, so a titration does not raise the monthly cost
  • Bills insurance for the clinical visits — the site states most members pay under $30 per visit
  • Runs a dedicated GLP-1 microdose program for people who want a lower starting dose

What to consider

  • The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
  • Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
  • The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
  • Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Hers

Site position #359 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Strengths

  • Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
  • Ongoing provider messaging and monthly care-team follow-ups described
  • Published membership and medication charges can be compared separately

What to consider

  • Required care membership is $39 first month, then $149 monthly, extra to medication
  • Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
  • Availability and medication prices depend on state, product, dose and plan
  • FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval

Featured provider

Found

Found scores 83.5/100 (B). The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard